Actinogen Medical Ltd (ACW) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.507x

Based on the latest financial reports, Actinogen Medical Ltd (ACW) has a cash flow conversion efficiency ratio of -0.507x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-9.29 Million ≈ $-6.58 Million USD) by net assets (AU$18.34 Million ≈ $12.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ACW cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Actinogen Medical Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Actinogen Medical Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Actinogen Medical Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Actinogen Medical Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Astro Malaysia Holdings Bhd KLSE:6399	0.127x
Globex Mining Enterprises Inc. TO:GMX	-0.028x
Beauty Health Co NASDAQ:SKIN	-0.101x
Consolidated Finvest & Holdings Limited NSE:CONSOFINVT	-0.002x
MFC Asset Management Public Company Limited BK:MFC	0.008x
EN Shoham Business Ltd TA:SHOM	-0.068x
Coffee Day Enterprises Limited NSE:COFFEEDAY	0.025x
Amanat Acquisition Corp Class A Ordinary Shares NASDAQ:AMAN	N/A

Annual Cash Flow Conversion Efficiency for Actinogen Medical Ltd (2008–2025)

The table below shows the annual cash flow conversion efficiency of Actinogen Medical Ltd from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see ACW company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$18.34 Million ≈ $12.97 Million	AU$-7.56 Million ≈ $-5.35 Million	-0.412x	+52.12%
2024-06-30	AU$19.70 Million ≈ $13.94 Million	AU$-16.95 Million ≈ $-11.99 Million	-0.861x	-32.65%
2023-06-30	AU$13.41 Million ≈ $9.49 Million	AU$-8.70 Million ≈ $-6.15 Million	-0.649x	-48.20%
2022-06-30	AU$21.74 Million ≈ $15.38 Million	AU$-9.52 Million ≈ $-6.73 Million	-0.438x	-343.34%
2021-06-30	AU$17.46 Million ≈ $12.35 Million	AU$-1.72 Million ≈ $-1.22 Million	-0.099x	+62.35%
2020-06-30	AU$10.89 Million ≈ $7.70 Million	AU$-2.86 Million ≈ $-2.02 Million	-0.262x	+60.87%
2019-06-30	AU$15.66 Million ≈ $11.08 Million	AU$-10.50 Million ≈ $-7.43 Million	-0.670x	-46.20%
2018-06-30	AU$17.26 Million ≈ $12.21 Million	AU$-7.91 Million ≈ $-5.60 Million	-0.458x	-287.20%
2017-06-30	AU$9.37 Million ≈ $6.63 Million	AU$-1.11 Million ≈ $-784.55K	-0.118x	+71.51%
2016-06-30	AU$12.13 Million ≈ $8.58 Million	AU$-5.04 Million ≈ $-3.57 Million	-0.416x	-71.57%
2015-06-30	AU$15.36 Million ≈ $10.87 Million	AU$-3.72 Million ≈ $-2.63 Million	-0.242x	+32.96%
2014-06-30	AU$1.21 Million ≈ $857.43K	AU$-437.84K ≈ $-309.80K	-0.361x	+44.08%
2013-06-30	AU$194.35K ≈ $137.52K	AU$-125.56K ≈ $-88.85K	-0.646x	+72.79%
2012-06-30	AU$346.99K ≈ $245.52K	AU$-823.94K ≈ $-582.99K	-2.375x	-208.31%
2011-06-30	AU$1.05 Million ≈ $740.20K	AU$-805.70K ≈ $-570.09K	-0.770x	-23.70%
2010-06-30	AU$1.17 Million ≈ $826.62K	AU$-727.37K ≈ $-514.66K	-0.623x	-116.57%
2009-06-30	AU$1.90 Million ≈ $1.35 Million	AU$-546.87K ≈ $-386.95K	-0.287x	-106.93%
2008-06-30	AU$2.86 Million ≈ $2.02 Million	AU$-397.22K ≈ $-281.06K	-0.139x	--

About Actinogen Medical Ltd

AU:ACW Australia Biotechnology

Market Cap

$78.71 Million

AU$111.25 Million AUD

Market Cap Rank

#20206 Global

#669 in Australia

Share Price

AU$0.04

Change (1 day)

-2.78%

52-Week Range

AU$0.02 - AU$0.07

All Time High

AU$0.18